Europe Pandemrix suspect, one of H1N1 vaccine, to be responsible for narcolepsy. These last two years, many countries have indeed been a marked increase in the incidence of this disease, usually rare
According to the Finnish National Institute of Health, Pandemrix, the main vaccine used against H1N1, was responsible cases of narcolepsy. A chronic neurological disease that is characterized by bouts of severe drowsiness or sudden loss of muscle tone. Typically, this condition is rare and Finland not counted a dozen cases per year. But these last two years, nearly 60 young people aged 4 to 19 reported illness. Among them, 90% had just been vaccinated.
Last August, Sweden had already sounded the alarm indicating an increased incidence of the disease. Similarly in France, where a score of cases have been recorded between 2009 and 2010. "The troubling cases by age of onset and severity unusual" says the newspaper Le Figaro Professor Yves Dauvilliers, neurologist and specialist in narcolepsy.
For the Finnish authorities, "the association is so obvious that it is unlikely that other factors may explain this phenomenon entirely alone." But it is possible that this link is "a joint effect of the vaccine and one or more other factors." To confirm these hypotheses must await the results of the final report of the Finnish Institute in August 2011 and those of the investigation launched by the European Medicines Agency.
http://www.maxisciences.com/grippe-h1n1/le-vaccin-anti-h1n1-at-il-provoque-des-cas-de-narcolepsie_art12290.html
0 comments:
Post a Comment